相关实验视频

Updated: Jun 29, 2025

Circumscribed Capsular Infarct Modeling Using a Photothrombotic Technique

Circumscribed Capsular Infarct Modeling Using a Photothrombotic Technique

Published on: June 2, 2016

在灾难性抗脂综合征 (CAPS) 中心脏参与:从"CAPS注册"中吸取教训

Isaac Pons¹, Alba Jeréz², Gerard Espinosa³

¹Department of Autoimmune Diseases, Reference Centre for Systemic Autoimmune Diseases (UEC/CSUR) of the Catalan and Spanish Health Systems-Member of ERNReCONNET, Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain; Department of Internal Medicine, Althaia Xarxa Assistencial Universitària de Manresa, Facultat de Medicina, Universitat de Vic-Universitat Central de Catalunya (uVic-UCC), Manresa, Catalonia, Spain.

Seminars in arthritis and rheumatism

|March 29, 2024

概括

灾难性抗脂综合征 (CAPS) 经常涉及到心脏,经常伴随脏问题. 这种心脏参与,以微血栓症为特征,不会增加CAPS患者的死亡率.

科学领域:

类风湿病学类风湿病学
心脏病学心脏病学
内部医学内部医学

背景情况:

灾难性抗脂综合征 (CAPS) 是一种罕见的,严重的自身免疫性疾病,其特征是广泛的血栓形成.
心脏参与是CAPS的严重并发症,但其患病率和相关因素需要进一步阐明.

研究的目的:

分析CAPS心脏病患者的人口,临床和实验室特征.
为了确定与CAPS中心脏参与相关的独立因素.

主要方法:

对"CAPS注册"数据库的分析.
包括749名患者和778名CAPS事件.
进行了单变量和多变量统计分析.

主要成果:

超过一半 (52%) 的CAPS患者患有心脏病,心力衰竭,门疾病和心肌梗塞是最常见的.
心脏干扰与中风,肺梗塞,脏梗塞,急性损伤和直视视网膜炎的频率增加有显著的关联.
急性损伤是心脏参与的唯一独立预测因素 (OR 1.068,p < 0.001).
心脏血栓性微血管病变在尸检/活检样本中普遍存在 (83%).

结论:

心脏干扰是CAPS的常见表现,通常与脏干扰有关.
心脏微血栓是受影响患者的关键病理发现.
重要的是,CAPS中的心脏参与与死亡率的增加无关.

关键词:

抗脂抗体是一种抗脂抗体.抗脂综合征是一种抗脂综合征.涉及到心脏的情况.灾难性的抗脂蛋白综合征这是一种狼抗凝剂.门参与的情况

更多相关视频

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

相关概念视频

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...